Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.10
Delayed Data
As of Nov 15
 -0.0499 / -4.34%
Today’s Change
1.05
Today|||52-Week Range
1.65
-20.29%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.15
Today’s open1.13
Day’s range1.05 - 1.14
Volume343,411
Average volume (3 months)212,000
Market cap$133.2M
Data as of 4:00pm ET, 11/15/2018

Growth & Valuation

Earnings growth (last year)+21.88%
Earnings growth (this year)--
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales2,583.39
Price/Book4.58

Competitors

 Today’s
change
Today’s
% change
CSBRChampions Oncology I...+0.51+4.22%
MRSNMersana Therapeutics...+0.34+5.41%
ONVOOrganovo Holdings In...-0.01-0.91%
XBITXBiotech Inc+0.16+3.96%
Data as of 4:00pm ET, 11/15/2018

Financials

Next reporting dateFebruary 6, 2019
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$50.0K
Annual profit (last year)-$26.1M
Net profit margin-52,252.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Co-Chief Executive Officer
Zami Aberman
President, Co-Chief Executive Officer &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts